Related Experiment Video
Updated: Nov 23, 2025

Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock
Published on: June 12, 2021
Management of acute cardiovascular events in patients with COVID-19
Chia-Te Liao1,2,3, Wei-Ting Chang1,4,5, Wen-Liang Yu6,7
1Department of Cardiology, Chi Mei Medical Center, 71004, Tainan, Taiwan.
Insights
This review offers guidance for managing critical cardiovascular diseases during the COVID-19 pandemic. It addresses ST-elevation myocardial infarction (STEMI) and other emergencies, prioritizing patient and clinician safety.
Area of Science:
- Cardiology
- Infectious Diseases
- Public Health
Background:
- Coronavirus disease 2019 (COVID-19), caused by SARS-CoV-2, presents significant morbidity and mortality.
- COVID-19 can lead to cardiovascular damage, worsening patient prognosis.
- Managing critical cardiovascular events during the pandemic requires balancing infectious disease control with optimal patient care.
Purpose of the Study:
- To provide comprehensive guidance for managing critical cardiovascular diseases during the COVID-19 epidemic.
- To address specific conditions including ST-segment elevation myocardial infarction (STEMI), non-STEMI acute coronary syndrome, cardiogenic shock, acute heart failure, cardiopulmonary resuscitation, and advanced care planning.
- To ensure prompt and optimal treatments while considering clinician safety and healthcare capacity.
Main Methods:
- This is a review article.
- It synthesizes current knowledge and expert recommendations.
- Focuses on critical cardiovascular conditions and their management during the COVID-19 pandemic.
Main Results:
- Cardiovascular injury is a significant complication of COVID-19, impacting prognosis.
- Effective management strategies must integrate infectious control measures.
- The review outlines approaches for STEMI, non-STEMI ACS, cardiogenic shock, acute heart failure, CPR, and care planning.
Conclusions:
- Integrated management protocols are crucial for critical cardiovascular diseases amidst the COVID-19 pandemic.
- Guidance addresses the unique challenges posed by SARS-CoV-2 infection.
- Optimizing care requires a multi-faceted approach considering patient outcomes and healthcare system constraints.
Abstract:
The pandemic of coronavirus disease 2019 (COVID-19) caused by the newly discovered virus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), had been noticed to have high morbidity and mortality. Apart from pneumonia, COVID-19 can also cause damage to the cardiovascular system, and co-occurring with cardiovascular injury leads to a poorer prognosis. Besides, amid the pandemic of COVID-19, the management of critical cardiovascular events needs to further account for the highly infectious coronavirus, prompt and optimal treatments, clinician's safety, and healthcare provider's capacity. This review article aims to provide more comprehensive and appropriate guidance for the management of critical cardiovascular disease, including ST-segment elevation myocardial infarction (STEMI), non-STEMI acute coronary syndrome, cardiogenic shock, acute heart failure, cardiopulmonary resuscitation, and advanced care planning, during the COVID-19 epidemic.
Related Concept Videos
Acute Coronary Syndrome IV: Interprofessional Care
Acute Coronary Syndrome V: Nursing Management
Myocarditis III: Medical Management
Heart Failure V: Medical Management
Cardiopulmonary Resuscitation IV: Pharmacological Management
Pericarditis IV: Nursing Management

